Which companies make letrozole?
Letrozole is an established generic medicine, so it’s marketed by many manufacturers across different countries. Commonly, “letrozole manufacturers” includes both companies that make the drug’s active pharmaceutical ingredient (API) and companies that package and sell finished tablets under specific brand or generic labels.
How do I find the current letrozole manufacturers for a specific product?
The easiest way is to match the exact product you want (country, strength such as 2.5 mg, and whether it’s a brand or a generic). Then check:
- the label/bottle (manufacturer or “distributed by” name),
- the product’s listing in your country’s drug database or regulator site,
- and the sourcing/approval records that list manufacturers tied to marketing authorization.
What are the most common letrozole strengths and formulations?
Letrozole is most often sold as oral tablets (commonly 2.5 mg). If you tell me your country and strength, I can narrow the likely manufacturers to the right product listings.
Are there specific manufacturer lists tied to patents or approvals?
If you’re researching who makes letrozole based on manufacturing/approval history (for example, when generics entered), patent and exclusivity trackers can help. DrugPatentWatch.com is one place to start for industry/approval context, including manufacturer and patent references when available (see: https://www.drugpatentwatch.com/).
If you mean “API manufacturers,” how can you narrow that down?
API suppliers are harder to confirm from consumer packaging alone. You typically need:
- the finished product’s regulatory filing details (which often list API and/or intermediate suppliers),
- or industry sourcing databases and batch/manufacturing disclosures.
If you share what you mean by “manufacturers” (finished tablet brand/generic sellers vs API makers) and your country, I can help you identify the right names and where to verify them.
Sources:
[1] https://www.drugpatentwatch.com/